Ryan Cross

1.6k total citations
31 papers, 1.2k citations indexed

About

Ryan Cross is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ryan Cross has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 12 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Ryan Cross's work include CAR-T cell therapy research (19 papers), Nanowire Synthesis and Applications (8 papers) and Immunotherapy and Immune Responses (7 papers). Ryan Cross is often cited by papers focused on CAR-T cell therapy research (19 papers), Nanowire Synthesis and Applications (8 papers) and Immunotherapy and Immune Responses (7 papers). Ryan Cross collaborates with scholars based in Australia, United States and Sweden. Ryan Cross's co-authors include Misty R. Jenkins, Alexander J. Davenport, Phillip K. Darcy, Joseph A. Trapani, Michael H. Kershaw, Paul A. Beavis, Paul J. Neeson, H. Miles Prince, David Ritchie and Katherine A. Watson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Ryan Cross

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan Cross Australia 14 815 436 410 291 173 31 1.2k
Alexander J. Davenport Australia 12 859 1.1× 478 1.1× 273 0.7× 296 1.0× 205 1.2× 24 1.1k
Lauren Giuffrida Australia 12 893 1.1× 705 1.6× 379 0.9× 213 0.7× 172 1.0× 14 1.3k
Shengmeng Di China 15 559 0.7× 411 0.9× 231 0.6× 193 0.7× 124 0.7× 23 985
Dongrui Wang United States 17 1.4k 1.7× 688 1.6× 688 1.7× 480 1.6× 275 1.6× 39 1.9k
Jenny J. Hong United States 12 800 1.0× 448 1.0× 614 1.5× 108 0.4× 169 1.0× 23 1.4k
Jason Plotkin United States 8 1.6k 2.0× 778 1.8× 603 1.5× 569 2.0× 499 2.9× 8 2.0k
Darya Alizadeh United States 13 942 1.2× 514 1.2× 417 1.0× 393 1.4× 220 1.3× 25 1.3k
Linchun Jin United States 10 533 0.7× 336 0.8× 378 0.9× 260 0.9× 115 0.7× 18 1.1k
Robyn A. Wong United States 9 521 0.6× 280 0.6× 402 1.0× 133 0.5× 126 0.7× 12 920
Avraham J. Treves Israel 17 1.1k 1.3× 913 2.1× 452 1.1× 88 0.3× 224 1.3× 25 1.5k

Countries citing papers authored by Ryan Cross

Since Specialization
Citations

This map shows the geographic impact of Ryan Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Cross more than expected).

Fields of papers citing papers by Ryan Cross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Cross. The network helps show where Ryan Cross may publish in the future.

Co-authorship network of co-authors of Ryan Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Cross. A scholar is included among the top collaborators of Ryan Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Cross. Ryan Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cross, Ryan, et al.. (2026). Progress in the development of cytokine armoured CAR T cells. Nature reviews. Immunology.
2.
Nouri, Yasmin, Nancy Dalton, Stacie Shiqi Wang, et al.. (2025). Defining the extracellular matrix for targeted immunotherapy in adult and pediatric brain cancer. npj Precision Oncology. 9(1). 184–184. 2 indexed citations
3.
Wang, Stacie Shiqi, Lisa M. Ebert, Alexander J. Davenport, et al.. (2024). EphA3-targeted chimeric antigen receptor T cells are effective in glioma and generate curative memory T cell responses. Journal for ImmunoTherapy of Cancer. 12(8). e009486–e009486. 8 indexed citations
4.
Wang, Stacie Shiqi, Alexander J. Davenport, Katherine A. Watson, et al.. (2023). HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma. Neuro-Oncology Advances. 5(1). vdad024–vdad024. 15 indexed citations
5.
Watson, Katherine A., et al.. (2023). Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma. Clinical & Translational Immunology. 12(3). e1440–e1440. 10 indexed citations
6.
Wang, Stacie Shiqi, Katherine A. Watson, Nicole A. Mifsud, et al.. (2023). Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma. Molecular Therapy — Oncolytics. 30. 167–180. 3 indexed citations
7.
Wang, Stacie Shiqi, Nicole A. Mifsud, Pouya Faridi, et al.. (2023). A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. Frontiers in Oncology. 13. 1192448–1192448. 7 indexed citations
8.
Cross, Ryan, et al.. (2023). Synthetic biology, genetic circuits and machine learning: a new age of cancer therapy. Molecular Oncology. 17(6). 946–949. 6 indexed citations
9.
Moujalled, Diane, Adam Southon, Kerstin Brinkmann, et al.. (2022). BH3 mimetic drugs cooperate with Temozolomide, JQ1 and inducers of ferroptosis in killing glioblastoma multiforme cells. Cell Death and Differentiation. 29(7). 1335–1348. 28 indexed citations
10.
Elazar, Assaf, Jonathan J. Weinstein, Raphael Trenker, et al.. (2022). De novo-designed transmembrane domains tune engineered receptor functions. eLife. 11. 34 indexed citations
11.
Cross, Ryan, Richard P. Redvers, Melissa J. Davis, et al.. (2022). MicroRNA-21 is immunosuppressive and pro-metastatic via separate mechanisms. Oncogenesis. 11(1). 38–38. 25 indexed citations
12.
Cross, Ryan, et al.. (2019). The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells. International Journal of Molecular Sciences. 21(1). 204–204. 31 indexed citations
13.
Davenport, Alexander J., Ryan Cross, Katherine A. Watson, et al.. (2018). Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity. Proceedings of the National Academy of Sciences. 115(9). E2068–E2076. 244 indexed citations
14.
Beavis, Paul A., Melissa A. Henderson, Lauren Giuffrida, et al.. (2017). Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy. Journal of Clinical Investigation. 127(3). 929–941. 259 indexed citations
15.
Millen, Rosemary, Jordane Malaterre, Ryan Cross, et al.. (2016). Immunomodulation by MYB is associated with tumor relapse in patients with early stage colorectal cancer. OncoImmunology. 5(7). e1149667–e1149667. 15 indexed citations
16.
Davenport, Alexander J., Misty R. Jenkins, Ryan Cross, et al.. (2015). CAR-T Cells Inflict Sequential Killing of Multiple Tumor Target Cells. Cancer Immunology Research. 3(5). 483–494. 112 indexed citations
17.
Sampurno, Shienny, Ryan Cross, Helen Pearson, et al.. (2015). Myb via TGFβis required for collagen type 1 production and skin integrity. Growth Factors. 33(2). 102–112. 3 indexed citations
18.
Jenkins, Misty R., Ryan Cross, Carmen S. Yong, et al.. (2015). CAR-T Cells Are Serial Killers of Tumor Cells. Blood. 126(23). 3088–3088. 1 indexed citations
19.
Steel, Rohan, Ryan Cross, Sarah Ellis, & Robin L. Anderson. (2012). Hsp70 Architecture: The Formation of Novel Polymeric Structures of Hsp70.1 and Hsc70 after Proteotoxic Stress. PLoS ONE. 7(12). e52351–e52351. 10 indexed citations
20.
Drabsch, Yvette, Ryan Cross, Dane Cheasley, et al.. (2011). MYB Is Essential for Mammary Tumorigenesis. Cancer Research. 71(22). 7029–7037. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander J. Davenport Breakdown of academic impact, for papers by Lauren Giuffrida Breakdown of academic impact, for papers by Shengmeng Di Breakdown of academic impact, for papers by Dongrui Wang Breakdown of academic impact, for papers by Jenny J. Hong Breakdown of academic impact, for papers by Jason Plotkin Breakdown of academic impact, for papers by Darya Alizadeh Breakdown of academic impact, for papers by Linchun Jin Breakdown of academic impact, for papers by Robyn A. Wong Breakdown of academic impact, for papers by Avraham J. Treves
Rankless by CCL
2026